Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001912126 | SCV002140846 | pathogenic | Glycogen storage disease, type IV; Glycogen storage disease IV, classic hepatic | 2024-01-20 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp160*) in the GBE1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GBE1 are known to be pathogenic (PMID: 15452297, 20058079). This variant is present in population databases (rs776943352, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with GBE1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1376912). For these reasons, this variant has been classified as Pathogenic. |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV002252715 | SCV002522985 | likely pathogenic | See cases | 2022-01-12 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PVS1, PM2 |
Baylor Genetics | RCV003464198 | SCV004198725 | likely pathogenic | Glycogen storage disease, type IV | 2024-03-03 | criteria provided, single submitter | clinical testing |